Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ibexx who wrote (932)	5/5/1999 6:29:00 PM
From: silInv	Read Replies (1) of 965

Ibexx and thread, New England Journal of Medicine Reports REMICADE(TM) Effective for Serious Complication of Crohn's Disease biz.yahoo.com Do we really need a takover to achieve higher price or it is better for CNTO to stay independent? RESEARCH ALERT - Centocor downgraded NEW YORK, May 5 (Reuters) - ABN Amro said Wednesday it cut its rating on shares of biotechnology firm, Centocor (CNTO - news) to an outperform from buy. -- Further details were not immediately available from the brokerage. -- Centocor's share price was down 3-1/4 at 45-7/8 on the Nasdaq stock market. biz.yahoo.com silInv

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next